Kevin James Craig sold $213k of ATAI
Chief Medical Officer at AtaiBeckley Inc.. 42,579 shares at an average of $5.00, traded Apr 20, 2026, filed Apr 22, 2026.
Score components
- +15RoleOfficer
- +12Trade size$213k at market
- +20Share of holdings soldSold 83% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -, 3m -0.6%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-26-016169, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | MOption exercise Common Stock10b5-1 | +27,280 | $1.50 | $41k | 35,717 | Apr 22, 2026 |
| Apr 20, 2026 | MOption exercise Common Stock10b5-1 | +15,299 | $1.84 | $28k | 51,016 | Apr 22, 2026 |
| Apr 20, 2026 | SOpen-market sale Common Stock10b5-1 | -42,579 | $5.00 | $213k | 8,437 | Apr 22, 2026 |
| Apr 20, 2026 | MOption exercise Stock Optionderivative10b5-1 | -27,280 | $0.00 | $0 | 706,859 | Apr 22, 2026 |
| Apr 20, 2026 | MOption exercise Stock Optionderivative10b5-1 | -15,299 | $0.00 | $0 | 372,701 | Apr 22, 2026 |
Related signals
Other insiders at AtaiBeckley Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 33Weak | AtaiBeckley Inc. | Robert Hershberg director | $496k 100,000 shares | -50% | |
| 33Weak | AtaiBeckley Inc. | Gerd Kochendoerfer Chief Operating Officer | $250k 50,000 shares | -100% | |
| 27Weak | AtaiBeckley Inc. | Kevin James Craig Chief Medical Officer | $192k 42,579 shares | -83% | |
| 15Weak | AtaiBeckley Inc. | Kevin James Craig Chief Medical Officer | $355k 100,000 shares | -92% | |
| 26Weak | ATAIsell AtaiBeckley Inc. | Cosmo Feilding-Mellen director | $154k 39,594 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.